Anaptysbio (ANAB) Return on Equity (2017 - 2025)
Historic Return on Equity for Anaptysbio (ANAB) over the last 9 years, with Q3 2025 value amounting to 2.28%.
- Anaptysbio's Return on Equity rose 58000.0% to 2.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.28%, marking a year-over-year increase of 58000.0%. This contributed to the annual value of 1.83% for FY2024, which is 8900.0% down from last year.
- According to the latest figures from Q3 2025, Anaptysbio's Return on Equity is 2.28%, which was up 58000.0% from 24.76% recorded in Q2 2025.
- Anaptysbio's Return on Equity's 5-year high stood at 24.76% during Q2 2025, with a 5-year trough of 5.9% in Q2 2024.
- Its 5-year average for Return on Equity is 0.28%, with a median of 0.4% in 2022.
- As far as peak fluctuations go, Anaptysbio's Return on Equity crashed by -51400bps in 2024, and later soared by 306600bps in 2025.
- Over the past 5 years, Anaptysbio's Return on Equity (Quarter) stood at 0.15% in 2021, then plummeted by -162bps to 0.4% in 2022, then crashed by -283bps to 1.53% in 2023, then fell by -22bps to 1.87% in 2024, then skyrocketed by 222bps to 2.28% in 2025.
- Its Return on Equity was 2.28% in Q3 2025, compared to 24.76% in Q2 2025 and 2.68% in Q1 2025.